Radiation Oncology/Therapy: Page 115

Time doesn't diminish risk of cancer relapse after lumpectomy and RT
By Cynthia E. Keen
The risk of developing cancer again in the same breast after breast-conservation surgery and radiation therapy does not diminish over time, a long-term study of more than 1,000 women with stage I and stage II breast cancer has revealed.
July 20, 2008
Breast self-examination does not cut breast cancer mortality
By Reuters Health
NEW YORK (Reuters Health), Jul 16 - An analysis of data from two large population-based studies suggests that regular breast self-examination does not reduce breast cancer mortality and may actually have a harmful effect by increasing the number of biopsies performed for benign disease.
July 15, 2008
Reuterslogo
Smoking during radiation therapy reduces treatment benefit
By Cynthia E. Keen
Patients with non-small cell lung cancer who smoke during the weeks they receive radiation therapy may reduce their overall benefit of treatment. Smoking has a significant negative effect as measured by several factors for assessing radiation therapy's effectiveness, according to study results.
July 15, 2008
Treatment delays common in men with breast cancer
By Reuters Health
NEW YORK (Reuters Health), Jul 8 - Male breast cancer is often diagnosed at an advanced stage and axillary lymph node involvement is frequently seen at presentation, according to research presented at a conference organized by the European Society for Medical Oncology (ESMO).
July 7, 2008
Reuterslogo
Education reduces children's need for anesthesia during radiotherapy
By Reuters Health
NEW YORK (Reuters Health), Jul 7 - Among young patients with cancer, a psychoeducational intervention reduces the percentage of patients requiring anesthesia during radiation treatment, Swiss researchers report in Radiation Oncology.
July 6, 2008
Reuterslogo
Nucletron taps new CEO
By AuntMinnieEurope.com staff writers
Radiation oncology firm Nucletron of Veenendaal, Netherlands, has named Jos Lamers as CEO.
June 29, 2008
Siemens installs Artiste Solution in three sites
By AuntMinnieEurope.com staff writers
Siemens Healthcare's Artiste Solution accelerator for adaptive radiation therapy has been installed in three institutions.
June 24, 2008
Swiss study links prostate radiotherapy to higher colon cancer risk
By Cynthia E. Keen
Prostate cancer patients who receive external-beam radiation therapy had a higher risk of developing colon cancer during their lifetime, but the overall risk may be declining with new technology, Swiss researchers report in a study published in the International Journal of Cancer.
June 23, 2008
Elekta receives FDA nod
By AuntMinnieEurope.com staff writers
Swedish radiation oncology firm Elekta has received U.S. Food and Drug Administration 510(k) clearance for its Volumetric Intensity Modulated Arc Therapy technology.
June 16, 2008
Elekta launches virtual clinic
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta of Stockholm, Sweden, has debuted a virtual patient clinic online, the company reported.
June 12, 2008
Single-dose carboplatin as effective as radiation for early testicular cancer
By Reuters Health
NEW YORK (Reuters Health), Jun 4 - In men with surgically resected stage I seminoma, a single dose of carboplatin chemotherapy is as effective as two to three weeks of radiation therapy in preventing recurrence and is much less toxic, according to study findings.
June 3, 2008
Reuterslogo
DW-MRI shows value in RTP for head and neck cancer
By Barbara Boughton
A pilot study presented at the 2008 American Association for Cancer Research (AACR) meeting is the first to demonstrate the value of diffusion-weighted MRI for nodal staging in head and neck squamous cell carcinoma, according to investigators from Belgium.
June 2, 2008
Previous Page
Page 115 of 126
Next Page